BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18825719)

  • 1. Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis.
    Zoulim F; Radenne S; Ducerf C
    Liver Transpl; 2008 Oct; 14 Suppl 2():S1-7. PubMed ID: 18825719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis.
    Kanwal F; Farid M; Martin P; Chen G; Gralnek IM; Dulai GS; Spiegel BM
    Am J Gastroenterol; 2006 Sep; 101(9):2076-89. PubMed ID: 16968510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy versus combination therapy for the treatment of chronic hepatitis B.
    Carey I; Harrison PM
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1655-66. PubMed ID: 19852566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.
    Peng CY; Chien RN; Liaw YF
    J Hepatol; 2012 Aug; 57(2):442-50. PubMed ID: 22504333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
    Khokhar A; Afdhal NH
    Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
    Nishida T; Kobashi H; Fujioka S; Fujio K; Takaguchi K; Ikeda H; Kawaguchi M; Ando M; Araki Y; Higashi T; Shoji B; Takaki A; Iwasaki Y; Sakaguchi K; Shiratori Y; Yamamoto K
    J Gastroenterol Hepatol; 2008 May; 23(5):794-803. PubMed ID: 18086120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V; Craxì A
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus-related cirrhosis: natural history and treatment.
    Chu CM; Liaw YF
    Semin Liver Dis; 2006 May; 26(2):142-52. PubMed ID: 16673292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: Nucleoside analogues for the treatment of chronic hepatitis B.
    Younger HM; Bathgate AJ; Hayes PC
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1211-30. PubMed ID: 15606384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy for hepatitis B virus associated hepatic failure.
    Wang YM; Tang YZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):17-24. PubMed ID: 19208509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis.
    Sadler MD; Coffin CS; Lee SS
    Expert Opin Pharmacother; 2013 Jul; 14(10):1363-9. PubMed ID: 23557465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy of decompensated hepatitis B virus-related cirrhosis.
    Chen GC; Yu T; Huang KH; Chen QK
    Chin Med J (Engl); 2012 Jan; 125(2):373-7. PubMed ID: 22340574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and risks of combination therapy for hepatitis B.
    Terrault NA
    Hepatology; 2009 May; 49(5 Suppl):S122-8. PubMed ID: 19399796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing management strategies in special patient populations.
    Sherman M
    Am J Gastroenterol; 2006; 101 Suppl 1():S26-31. PubMed ID: 16448449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special considerations and treatment of patients with HBV-HIV coinfection.
    Dieterich DT
    Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy for hepatitis B virus-related decompensated cirrhosis.
    Wang JY
    J Dig Dis; 2012 Nov; 13(11):555-7. PubMed ID: 23107441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
    Suzuki Y; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Miyakawa Y; Kumada H
    J Gastroenterol Hepatol; 2009 Mar; 24(3):429-35. PubMed ID: 19226381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF; Herrero JI
    An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.